Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: G
Results 51 - 60 of 306 shown below

  • gastric carcinogenesis

    M Tatsuta, H Iishi, M Baba, R Hirasawa, H Yano, N Sakai and A Nakaizumi

    Attenuation by all-trans-retinoic acid of sodium chloride-enhanced gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats

    doi:10.1038/sj.bjc.6690117

  • gastric carcinoma

    J Wayman, M K Bennett, S A Raimes and S M Griffin

    The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction

    doi:10.1038/sj.bjc.6600252

  • J Yu, W K Leung, M P A Ebert, R W L Leong, P C H Tse, M W Y Chan, A H C Bai, K F To, P Malfertheiner and J J Y Sung

    Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer

    doi:10.1038/sj.bjc.6600940

  • S-H Lee, W K Kang, J Park, H Y Kim, J H Kim, S I Lee, J O Park, K Kim, C W Jung, Y S Park, Y-H Im, M H Lee and K Park

    Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer

    advance online publication, 2004-06-08 00:00:00.000;

    doi:10.1038/sj.bjc.6601891

  • S T Kim, W K Kang, J H Kang, K W Park, J Lee, S-H Lee, J O Park, K Kim, W S Kim, C W Jung, Y S Park, Y-H Im and K Park

    Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer

    advance online publication, 2005-05-03 00:00:00.000;

    doi:10.1038/sj.bjc.6602575

  • Y Tajima, K Yamazaki, R Makino, N Nishino, Y Masuda, S Aoki, M Kato, K Morohara and M Kusano

    Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach

    advance online publication, 2007-01-30 00:00:00.000;

    doi:10.1038/sj.bjc.6603583

  • C-C Chen, L-T Chen, T-C Tsou, W-Y Pan, C-C Kuo, J-F Liu, S-C Yeh, F-Y Tsai, H-P Hsieh and J-Y Chang

    Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil

    advance online publication, 2007-07-03 00:00:00.000;

    doi:10.1038/sj.bjc.6603866

  • T Boysen, M Mohammadi, M Melbye, S Hamilton-Dutoit, B Vainer, A V Hansen, J Wohlfahrt and J Friborg

    EBV-associated gastric carcinoma in high- and low-incidence areas for nasopharyngeal carcinoma

    advance online publication, 2009-07-14 00:00:00.000;

    doi:10.1038/sj.bjc.6605168

  • S Y Leung and J C I Ho

    Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese

    doi:10.1038/sj.bjc.6690092

  • T Yoshikawa, K Suzuki, O Kobayashi, M Sairenji, H Motohashi, A Tsuburaya, Y Nakamura, A Shimizu, S Yanoma and Y Noguchi

    Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer

    doi:10.1038/sj.bjc.6690182

  • E Otsuji, T Yamaguchi, K Sawai, K Okamoto and T Takahashi

    Total gastrectomy with simultaneous pancreaticosplenectomy or splenectomy in patients with advanced gastric carcinoma

    doi:10.1038/sj.bjc.6690285

  • A U Jawhari, M Noda, M J G Farthing and M Pignatelli

    Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines

    doi:10.1038/sj.bjc.6690358

  • K Dolan, R Sutton, S J Walker, A I Morris, F Campbell and E M I Williams

    New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology

    doi:10.1038/sj.bjc.6690429

  • S A Watson, T M Morris, H M Collins, L J Bawden, K Hawkins and E A Bone

    Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA

    doi:10.1038/sj.bjc.6690645

  • Y Kitadai, Y Takahashi, K Haruma, K Naka, K Sumii, H Yokozaki, W Yasui, N Mukaida, Y Ohmoto, G Kajiyama, I J Fidler and E Tahara

    Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice

    doi:10.1038/sj.bjc.6690742

  • D H Brewster, L A Fraser, P A McKinney and R J Black

    Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland

    doi:10.1054/bjoc.2000.1110

  • N Futamura, S Nakamura, M Tatematsu, Y Yamamura, R Kannagi and H Hirose

    Clinicopathologic significance of sialyl Le xexpression in advanced gastric carcinoma

    doi:10.1054/bjoc.2000.1484

  • M J Baek, H Kang, S E Kim, J H Park, J S Lee, Y-K Paik and H Kim

    Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability

    doi:10.1054/bjoc.2001.2051

  • H U Barthelmes, E Niederberger, T Roth, K Schulte, W C Tang, F Boege, H-H Fiebig, G Eisenbrand and D Marko

    Lycobetaine acts as a selective topoisomerase IIbeta poison and inhibits the growth of human tumour cells

    doi:10.1054/bjoc.2001.2142

  • Gastric cardia

    Y Tajima, K Yamazaki, R Makino, N Nishino, Y Masuda, S Aoki, M Kato, K Morohara and M Kusano

    Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach

    advance online publication, 2007-01-30 00:00:00.000;

    doi:10.1038/sj.bjc.6603583

  • gastric MALT lymphoma

    K Fujimori, S Shimodaira, T Akamatsu, K Furihata, T Katsuyama and S Hosaka

    Effect of Helicobacter pylori eradication on ongoing mutation of immunoglobulin genes in gastric MALT lymphoma

    advance online publication, 2005-01-11 00:00:00.000;

    doi:10.1038/sj.bjc.6602262

  • gastrin

    M Yao, D H Song, B Rana and M M Wolfe

    COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer

    doi:10.1038/sj.bjc.6600495

  • E Hofsli, L Thommesen, F Yadetie, M Langaas, W Kusnierczyk, U Falkmer, A K Sandvik and A Laegreid

    Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells

    doi:10.1038/sj.bjc.6602535

  • I Chau, D Cunningham, C Russell, A R Norman, T Kurzawinski, P Harper, P Harrison, G Middleton, F Daniels, T Hickish, J Prendeville, P J Ross, B Theis, R Hull, M Walker, N Shankley, B Kalindjian, G Murray, A Gillbanks and J Black

    Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials

    advance online publication, 2006-04-04 00:00:00.000;

    doi:10.1038/sj.bjc.6603058

  • A M Grabowska, J Hughes and S A Watson

    Use of interfering RNA to investigate the role of endogenous gastrin in the survival of gastrointestinal cancer cells

    advance online publication, 2007-01-30 00:00:00.000;

    doi:10.1038/sj.bjc.6603588

  • A M Grabowska, C A Berry, J Hughes, M Bushell, A E Willis and S A Watson

    A gastrin transcript expressed in gastrointestinal cancer cells contains an internal ribosome entry site

    advance online publication, 2008-04-08 00:00:00.000;

    doi:10.1038/sj.bjc.6604326

  • gastrin releasing peptide

    H S Chave, A C Gough, K Palmer, S R Preston and J N Primrose

    Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa

    doi:10.1054/bjoc.1998.0888

  • gastrin, CCK-2 receptors

    S A Watson, T M Morris, D F McWilliams, J Harris, S Evans, A Smith and P A Clarke

    Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence

    doi:10.1038/sj.bjc.6600509

  • Gastrin-releasing peptide

    C M Waters, A C MacKinnon, J Cummings, U Tufail-Hanif, D Jodrell, C Haslett and T Sethi

    Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6–11)-induced growth inhibi

    doi:10.1038/sj.bjc.6600957

  • D M Burns, B Walker, J Gray and J Nelson

    Breast cancer cell-associated endopeptidase EC 24.11 modulates proliferative response to bombesin

    doi:10.1038/sj.bjc.6690036

  • gastritis

    C Morgan, G J S Jenkins, T Ashton, A P Griffiths, J N Baxter, E M Parry and J M Parry

    Detection of p53 mutations in precancerous gastric tissue

    doi:10.1038/sj.bjc.6601302

  • K Kashiwagi, M Watanabe, T Ezaki, T Kanai, H Ishii, M Mukai and T Hibi

    Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis

    doi:10.1054/bjoc.1999.1154

  • gastro-oesophageal cancer

    S Slater, J Shamash, P Wilson, C J Gallagher and M L Slevin

    Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen

    doi:10.1038/sj.bjc.6600553

  • A B C Crumley, D C McMillan, M McKernan, A C McDonald and R C Stuart

    Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer

    advance online publication, 2006-02-14 00:00:00.000;

    doi:10.1038/sj.bjc.6602998

  • A B C Crumley, D C McMillan, M McKernan, J J Going, C J Shearer and R C Stuart

    An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer

    advance online publication, 2006-05-09 00:00:00.000;

    doi:10.1038/sj.bjc.6603150

  • M McKernan, D C McMillan, J R Anderson, W J Angerson and R C Stuart

    The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer

    advance online publication, 2008-02-12 00:00:00.000;

    doi:10.1038/sj.bjc.6604248

  • M M Eatock, D A Anthony, M El-Abassi, P Wilson, J Paul, M Smith, M Soukop and T R J Evans

    A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma

    doi:10.1054/bjoc.2000.1165